Cargando…

A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers

BACKGROUND AND OBJECTIVES: Influenza virosomes represent an innovative human-compatible antigen delivery system that has already proven its suitability for subunit vaccine design. The aim of the study was to proof the concept that virosomes can also be used to elicit high titers of antibodies agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genton, Blaise, Pluschke, Gerd, Degen, Lukas, Kammer, Andreas R., Westerfeld, Nicole, Okitsu, Shinji L., Schroller, Sandro, Vounatsou, Penelope, Mueller, Markus M., Tanner, Marcel, Zurbriggen, Rinaldo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001290/ https://www.ncbi.nlm.nih.gov/pubmed/17925866 http://dx.doi.org/10.1371/journal.pone.0001018

Ejemplares similares

A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial
por: Okitsu, Shinji L., et al.
Publicado: (2007)

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
por: Tamborrini, Marco, et al.
Publicado: (2011)

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
por: Cech, Patrick Georges, et al.
Publicado: (2011)

Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine
por: Tamborrini, Marco, et al.
Publicado: (2009)

Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
por: Thompson, Fiona M., et al.
Publicado: (2008)

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
por: Thompson, Fiona M., et al.
Publicado: (2011)

Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models
por: Tamborrini, Marco, et al.
Publicado: (2020)

Virosome: An engineered virus for vaccine delivery
por: Ali, Hasan, et al.
Publicado: (2023)

Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate
por: Fernandes, Bárbara, et al.
Publicado: (2022)

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability
por: Lederhofer, J., et al.
Publicado: (2018)

Virosome Presents Multimodel Cancer Therapy without Viral Replication
por: Saga, Kotaro, et al.
Publicado: (2013)

P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
por: Bomsel, M, et al.
Publicado: (2009)

Reconstruction of H(3)N(2) influenza virus based virosome in-vitro
por: Abdoli, Asghar, et al.
Publicado: (2013)

Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
por: Fonseca, Francisco Noé, et al.
Publicado: (2023)

Clonal Groupings in Serogroup X Neisseria meningitidis
por: Gagneux, Sébastien, et al.
Publicado: (2002)

Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine
por: Alicino, Cristiano, et al.
Publicado: (2014)

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015)

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)

Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan
por: Rasool, Muhammad Hidayat, et al.
Publicado: (2021)

A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs
por: Haach, Vanessa, et al.
Publicado: (2023)

Construction of influenza virosome from influenza A H1N1 PR8
por: Noori, Mehri, et al.
Publicado: (2011)

Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
por: Soema, Peter C., et al.
Publicado: (2014)

Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
por: Asadi, Khatereh, et al.
Publicado: (2021)

Comparison of Three Aspirin Formulations in Human Volunteers
por: Nordt, Sean Patrick, et al.
Publicado: (2011)

3IA Conference (3IA’2011)
por: Plemenos, Dimitri, et al.
Publicado: (2012)

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
por: Kamphuis, Tobias, et al.
Publicado: (2012)

A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes
por: Blom, Rebecca A. M., et al.
Publicado: (2016)

Erythro–Magneto–HA–Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs
por: Vizzoca, Alessio, et al.
Publicado: (2022)

Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever
por: D'Acremont, Valérie, et al.
Publicado: (2009)

The economic impact of schistosomiasis
por: Rinaldo, Daniele, et al.
Publicado: (2021)

Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity
por: Kumar, Varun, et al.
Publicado: (2021)

Bioavailability of a Lipidic Formulation of Curcumin in Healthy Human Volunteers
por: Pawar, Yogesh B., et al.
Publicado: (2012)

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals
por: Tamborrini, Marco, et al.
Publicado: (2023)

Rapid Urban Malaria Appraisal (RUMA) III: epidemiology of urban malaria in the municipality of Yopougon (Abidjan)
por: Wang, Shr-Jie, et al.
Publicado: (2006)

Rapid Urban Malaria Appraisal (RUMA) IV: Epidemiology of urban malaria in Cotonou (Benin)
por: Wang, Shr-Jie, et al.
Publicado: (2006)

Mass drug administration for malaria elimination: do we understand the settings well enough?
por: Hetzel, Manuel W., et al.
Publicado: (2018)

Bayesian geostatistical modelling of high-resolution [Formula: see text] exposure in Europe combining data from monitors, satellites and chemical transport models
por: Beloconi, Anton, et al.
Publicado: (2020)

Substantial Reduction in Particulate Matter Air Pollution across Europe during 2006–2019: A Spatiotemporal Modeling Analysis
por: Beloconi, Anton, et al.
Publicado: (2021)

Long-term air pollution exposure and COVID-19 case-severity: An analysis of individual-level data from Switzerland
por: Beloconi, Anton, et al.
Publicado: (2023)

Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_84b7srnh2929kjk5kp49j5l8vp